Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
09/2005
09/22/2005US20050209464 Dyeing composition; oxidation-dyeing keratin fibers
09/22/2005US20050209320 Compounds comprise an androgen receptor (AR) binding moiety which selectively targets the compounds to AR-expressing cancer cells, and a cytotoxic alkylating moiety, such as a nitrogen mustard moiety; (2R)-2-hydroxy-3-[(4-hydroxyphenyl)thio]-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
09/22/2005US20050209306 Crystalline [R-(R*,R*)]-2-(4-fluorophenyI)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl- 4-[(phenylamino)carbonyl]-1H-pyrrole-heptanoic acid calcium salt (2:1)
09/22/2005US20050209249 Use as antidiabetic agents, treating hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis; (3S, 5S)-4-([5-(Thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-sulfamoyl)-benzoic acid for example
09/22/2005US20050209222 Pharmaceutically active compounds and methods of use
09/22/2005US20050209217 3-Mercaptopyrrolidines as farnesyl protein transferase inhibitors
09/22/2005US20050209212 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; improvement over imipenem
09/22/2005US20050209162 Methods for monitoring IL-18
09/22/2005US20050208015 Glycerol derivative
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2558552A1 Sulphonylpyrroles as hdac inhibitors
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2558034A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/21/2005EP1577297A1 Process for the production of atorvastatin calcium in amorphous form
09/21/2005EP1577296A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their use
09/21/2005EP1577295A1 Process for preparing 2-oxo-1-pyrrolidine derivatives as intermediates
09/21/2005EP1577289A1 Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005EP1575914A1 Aromatic derivatives as hiv aspartyl protease inhibitors
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1575903A1 Compounds for the inhibition of rotamases
09/21/2005EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/21/2005EP1163217B1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
09/21/2005CN1671663A Pleuromutilin
09/21/2005CN1671658A Process for the manufacture of amino-pyrrolidine derivatives
09/21/2005CN1670016A Aryl pyrrole compounds with insecticidal, miticidal and fungicidal bioactivities and process for preparing same
09/21/2005CN1219764C W-carboxyaryl substituted diphenyl ureas as RAF kinase inhibitors
09/20/2005US6946568 Titanium, zirconium, hafnium, vandium, niobium or tantalum complexed with an imine and an amine, oxy or sulfide
09/20/2005US6946552 Refined routes to chlorin building blocks
09/20/2005US6946532 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
09/20/2005US6946523 Microelectronics; hermetic sealed packages
09/20/2005US6946481 Endothelin antagonists
09/20/2005US6946480 Glutaminyl based DPIV inhibitors
09/20/2005US6946475 Anticancer calcium channel blockers
09/20/2005US6946468 that inhibit farnesylation of mutant ras gene products; cancer; (2)-2-(2-methoxy-ethyl)-1-((cis)-3-sulfanyl-pyrrolidin-2-ylmethyl)-4-naphthoyl-piperazine
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005US6946005 Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2188796C Heterocyclylbenzonitriles
09/15/2005WO2005085322A1 Process for the preparation of activated polyethylene glycols
09/15/2005WO2005085275A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005WO2005085236A2 Caspase inhibitors and uses thereof
09/15/2005WO2005085193A1 Fluorescent chelates
09/15/2005WO2005085177A2 Biaryl amino acids and their use in dna binding oligomers
09/15/2005WO2005065050A3 Bicyclic compound
09/15/2005WO2005059037B1 Reagent for detecting an analyte
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005US20050203324 Impurity reduction in Olefin metathesis reactions
09/15/2005US20050203302 Preparation of atorvastatin
09/15/2005US20050203289 Functional biopolymer modification reagents and uses thereof
09/15/2005US20050203173 PI-3 kinase inhibitor prodrugs
09/15/2005US20050203170 Chalcones substitued with amine or amino acid-derived amide, specifically (S)-2-amino-3-hydroxypropanoic acid (2-methoxy-5-[2-methyl-3-oxo-3-(3,4,5-trimethoxyphenyl)propenyl]phenyl)amide hydrochloride; use inhibiting tubulin polymerization; antitumor agents
09/15/2005US20050203167 Diphenylmethyl compounds useful as muscarinic receptor antagonists
09/15/2005US20050203161 Diphenylmethyl compounds useful as muscarinic receptor antagonists
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203079 Serotonin (5-HT) 2c receptors; antidepressants, anxiolytic agents; 3-(3,4-Dichloro-phenyl)-3-hydroxy-1-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-pyrrolidin-2-one for example
09/15/2005US20050203031 Useful for the treatment of type 2 diabetes, impaired glucose tolerance and certain other conditions
09/15/2005US20050203030 Novel effectors of dipeptidyl peptidase IV
09/15/2005CA2557645A1 Caspase inhibitors and uses thereof
09/15/2005CA2557322A1 Inhibitors of hepatitis c virus ns3 protease
09/14/2005EP1572663A1 Biphenylcarboxamides
09/14/2005EP1572644A1 Process for producing n-methyl succinimide
09/14/2005EP1572643A2 Crystalline form f of atorvastatin hemi-calcium salt
09/14/2005EP1572642A1 3-pyrrolyl urea derivatives and their use as antiviral agents
09/14/2005EP1572641A1 Method for production of the r,r (or s,s) configuration of glycopyrronium stereoisomers
09/14/2005EP1572640A1 Asimadoline derivatives comprising covalently bonded acids
09/14/2005EP1572638A2 An improved process for the preparation of amorphous atorvastatin calcium salt (2:1)
09/14/2005EP1572632A1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
09/14/2005EP1572630A1 Antibacterial agents
09/14/2005EP1572615A1 Process for the synthesis of peptides containing a 4-hydorxy-proline substructure
09/14/2005EP1572072A2 Methods of treating infection by drug resistant bacteria
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005EP1392643B1 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
09/14/2005EP1289954B1 Serine protease inhibitors
09/14/2005EP1258250B1 Nerve protective drugs
09/14/2005EP1200402B1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
09/14/2005CN1669361A Organic light emitting devices having carrier blocking layers comprising metal complexes
09/14/2005CN1668584A Pyrrole derivatives as antimycobacterial compounds
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/14/2005CN1668295A Medicinal composition
09/14/2005CN1666982A Mixtures and compounds from Antrodia camphorate myceliums and use thereof
09/14/2005CN1218919C Fluorene derivatives and their application
09/13/2005US6943269 Contrast media for angiography
09/13/2005US6943196 NF-κB inhibitor comprising phenylmethyl benzoquinone as the active ingredient
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/09/2005WO2005082849A1 Lactams as conformationally constrained peptidomimetic inhibitors
09/09/2005WO2005082848A2 Method for preparing pyrrolidine oximes
09/09/2005WO2005082847A1 Bicyclo derivative
09/09/2005WO2005082350A1 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005009373A3 Tyrosine kinase inhibitors
09/09/2005WO2004108636A3 Isotopically labeled chemically stable reagents and process for the synthesis thereof
09/09/2005CA2557444A1 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation
09/09/2005CA2555711A1 Maleiimide anti-tumor phosphatase inhibitors
09/09/2005CA2554767A1 Method for preparing pyrrolidine oximes
09/08/2005US20050197502 Treating N-methyl-2-pyrrolidone with an alumina that desorbs less than 100 mu mol/g of isobutylene between 225 degrees C. and 400 degrees C. in a standard tert-butyl alcohol dehydration test
09/08/2005US20050197501 Reacting calcium hydroxide with an ester derivative or protected ester derivative of the statin; rosuvastatin, pitavastatin and atorvastatin, simvastatin and lovastatin
09/08/2005US20050197500 Process for the synthesis of 1,3-diols
1 ... 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 ... 404